BGMS Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
454.0K
+35.1%
336.0K
-56.8%
778.0K
+16.8%
666.0K
+722.2%
81.0K
Cost of Revenue
339.0K
+31.9%
257.0K
-59.5%
635.0K
+16.5%
545.0K
+751.6%
64.0K
Gross Profit
115.0K
+45.6%
79.0K
-44.8%
143.0K
+18.2%
121.0K
+611.8%
17.0K
Operating Expenses
635.0K
+27.8%
497.0K
+27.8%
389.0K
-67.7%
1.2M
+19.8%
1.0M
R&D
0
0
0
+100.0%
-47000
0
SG&A
635.0K
+27.8%
497.0K
+27.8%
389.0K
-68.9%
1.3M
+24.5%
1.0M
Operating Income
-520000
-24.4%
-418000
-69.9%
-246000
+77.3%
-1082000
-9.6%
-987000
EBITDA
-520000
-24.4%
-418000
-70.6%
-245000
+77.3%
-1078000
-9.2%
-987000
Net Income
-449000
-10.9%
-405000
-105.6%
-197000
+67.8%
-611000
+38.2%
-988000
EPS (Basic)
$-0.07
+12.5%
$-0.08
-100.0%
$-0.04
+98.0%
$-1.99
-51.9%
$-1.31
EPS (Diluted)
$-0.07
+12.5%
$-0.08
-100.0%
$-0.04
+98.0%
$-1.99
-51.9%
$-1.31
Shares (Diluted)
6.6M
+18.3%
5.6M
+2.6%
5.5M
+7.0%
5.1M
+166.8%
1.9M
Bio Green Med Solution (BGMS) — Financials